Division Faculty


Faculty Profile:

Alan Barker, MD

Professor of Medicine
Division of Pulmonary and Critical Care Medicine, OHSU
Director, Respiratory Care
E-mail: barkera@ohsu.edu

Degrees:
  • BA - Carleton College, 1966
  • MD - University of Missouri Medical School, 1970


Residency:

  • Internal Medicine - University of Washington Affiliated Hospitals,
    1970-1973
  • Chief Resident - University of Washington Affiliated Hospitals,
    1973-1974


Fellowship:

  • Pulmonary Medicine - University of California, San Diego, 1974-1976


Research Interest:

  • Alpha-one antitrypsin deficiency; bronchiectasis


Clinical Interest:

  • Alpha-one antitrypsin deficiency; bronchiectasis, sarcoidosis, COPD, asthma, interstitial lung disease; critical care


Representative Publications:

  • O'Donnell AE, Barker AF, Ilowite JS, Fick RB, et al: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest, 113:1329-34, 1998.
  • Collaborative Effort. Alpha1-antitrypsin Deficiency Registry Study Group: Survival and FEV1 decline in individuals with severe deficiency of a1-antitrypsin. Am J Respir Crit Care Med, 158:49-59, 1998.
  • Barker AF : Bronchiectasis in COPD, in UpToDate in Pulmonary and Critical Care, Amer Thor Society, 1996-2005; updated every year
    (CD-ROM).
  • Barker AF : Bronchiectasis and localized airway/parenchymal disorders in Cecil Textbook of Medicine (21st edition); ed. Goldman L and Bennett JC, p 405-09, 2000.
  • Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker AF, Haranath SP, Pauwels RA, Kips JC, Drazen JM, Churg-Strauss Syndrome in patients receiving Montelukast as treatment for asthma. Chest, 117:708-13, 2000.
  • Schluchter MD, Stoller JK, Barker AF, Buist AS, Crystal RG, Donohue JF, Fallat RJ, Turino GM, Vriem CE, Wu MC for the Alpha 1-antitrypsin deficiency registry study group. Feasibility of a clinical local of augmentation therapy for a1 - antitrypsin deficiency. Am J Resp Crit Care Med 161:796-801, 2000.
  • Barker AF , Couch LC, Fiel SB, et al: Tobramycin solution for inhalation reduces sputum P. aeruginosa density in bronchiectasis. Am J Resp Crit Care Med, 162:481-85, 2000.
  • Barker AF : Bronchopulmonary aspergillosis in Kelly's Text of Internal Medicine. Ed. David Humes, 4th edition, 2000.
  • Barker AF: Medical Progress: Bronchiectasis. NEJM 346:1383, 2002.
  • Eden E, Hammel J, Rouhani F, Brantley M, Barker AF, Buist S, Fallat RJ, Stoller JK, Crystal RG, Turino GM and the alpha1-antitrypsin deficiency registry study group. Asthma features in severe α1 antitrypsin deficiency Chest, 123:765, 2003.


Biosketch:

Dr. Barker joined the Division of Pulmonary and Critical Care in 1976. He currently serves as Medical Director of Respiratory Care and Medical Director of the Pulmonary Function lab. In addition, Dr. Barker serves as Chair of the Respiratory Therapy Program at Mount Hood Community College. Dr. Barker also maintains active inpatient and outpatient practices in Pulmonary Medicine.

Dr. Barker has been recognized as a regional and national expert on AAT deficiency and in the treatment of patients with AAT deficiency with augmentation therapy and has published numerous journal articles on the subject. He is currently a Principal Investigator of a multi-center study of genetic modifiers in AAT deficiency. In addition, Dr. Barker is also recognized as an expert on bronchiectasis

Dr. Barker received his BA from Carleton College, Minnesota in 1966 and received his MD degree in 1970 from the University of Missouri Medical School. He then completed his residency in Internal Medicine at the University of Washington Affiliated Hospitals and served as Chief Resident from 1973 to 1974. Following this, Dr. Barker was a Pulmonary and Critical Care Medicine Fellow at the University of San Diego from 1974-1976.
0